Clinuvel Pharmaceuticals Limited

ASX:CUV Stock Report

Market Cap: AU$669.3m

Clinuvel Pharmaceuticals Limited Company Information

Clinuvel Pharmaceuticals Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Clinuvel Pharmaceuticals Limited
  • Ticker: CUV
  • Exchange: ASX
  • Founded: 1999
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: AU$669.287m
  • Shares Outstanding: 49.95m
  • Website: https://www.clinuvel.com

Location

  • Clinuvel Pharmaceuticals Limited
  • 535 Bourke Street
  • Level 22
  • Melbourne
  • Victoria
  • 3000
  • Australia


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
UR9DB (Deutsche Boerse AG)YesOrdinary SharesDEEURFeb 2001
CUVASX (Australian Securities Exchange)YesOrdinary SharesAUAUDFeb 2001
CLVL.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDFeb 2001
CUVCHIA (Chi-X Australia)YesOrdinary SharesAUAUDFeb 2001
CLVL.YOTCPK (Pink Sheets LLC)SPON ADR EA REP 1 ORD NPVUSUSDMay 2004
UR9ADB (Deutsche Boerse AG)SPON ADR EA REP 1 ORD NPVDEEURMay 2004

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/21 08:00
End of Day Share Price 2024/11/21 00:00
Earnings2024/06/30
Annual Earnings2024/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.